Pharmadrug Inc. (CSE:PHRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0100
0.00 (0.00%)
Jul 31, 2026, 9:30 AM EST

Pharmadrug Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.01
Revenue Growth
------98.98%
Gross Profit
-----0-0
Operating Income
-0.2-0.21-0.63-1.36-2.36-2.72
Net Income
-0.47-0.38-0.79-13.2-8.88-5.63
Earnings Per Share
-0.00-0.00-0.01-0.23-0.18-0.12
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.380.020.080.420.331.3
Total Debt
1.711.521.351.771.420.87
Net Cash (Debt)
-1.32-1.5-1.27-1.34-1.090.43
Net Cash Growth
------86.91%
Net Cash Per Share
-0.01-0.01-0.01-0.02-0.020.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.14-0.09-0.76-0.67-2.26-4.13
Capital Expenditures
------
Free Cash Flow
-0.14-0.09-0.76-0.67-2.26-4.13
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------30.75%
Operating Margin
------38806.68%
Pretax Margin
------61121.04%
Profit Margin
------80275.25%
FCF Margin
------58906.35%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----1701.89